Ultragenyx Pharmaceutical Inc. buy Robert W. Baird
Start price
30.01.24
/
50%
€40.80
Target price
30.01.25
€62.74
Performance (%)
1.96%
End price
31.01.25
€41.60
Summary
This prediction ended on 31.01.25 with a price of €41.60. With a performance of 1.96%, the BUY prediction by Robert_W__Baird for Ultragenyx Pharmaceutical Inc. closed with a slight gain. Robert_W__Baird has a follow-up prediction for Ultragenyx Pharmaceutical Inc. where he still thinks Ultragenyx Pharmaceutical Inc. is a Buy. Robert_W__Baird has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. | 0.000% | 0.000% | -30.476% |
| iShares Core DAX® | 0.323% | 2.208% | 21.610% |
| iShares Nasdaq 100 | 0.145% | -0.987% | 5.603% |
| iShares Nikkei 225® | 0.091% | -1.421% | 12.897% |
| iShares S&P 500 | 0.371% | -0.469% | 3.470% |
Comments by Robert_W__Baird for this prediction
In the thread Ultragenyx Pharmaceutical Inc. diskutieren
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) had its price target raised by analysts at Robert W. Baird from $57.00 to $68.00. They now have an "outperform" rating on the stock.
Ratings data for RARE provided by MarketBeat
In the thread Trading Ultragenyx Pharmaceutical Inc.
Die von Robert_W__Baird gewählte maximale Laufzeit wurde überschritten
Current prediction by Robert_W__Baird for Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€17.00
30.12.25
30.12.25
€39.91
30.12.26
30.12.26
0.00%
29.12.25
29.12.25
Stopped prediction by Robert_W__Baird for Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€36.00
31.05.24
31.05.24
€66.15
31.05.25
31.05.25
-17.78%
01.06.25
01.06.25